527 related articles for article (PubMed ID: 35006464)
1. E3 ubiquitin ligases: styles, structures and functions.
Yang Q; Zhao J; Chen D; Wang Y
Mol Biomed; 2021 Jul; 2(1):23. PubMed ID: 35006464
[TBL] [Abstract][Full Text] [Related]
2. Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.
Di Gregorio J; Appignani M; Flati V
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139010
[TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
4. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
5. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
6. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
7. The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy.
Wang X; Zhang Y; Wu Y; Cheng H; Wang X
Front Immunol; 2023; 14():1202633. PubMed ID: 37215134
[TBL] [Abstract][Full Text] [Related]
8. Overview of approaches for screening for ubiquitin ligase inhibitors.
Sun Y
Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions.
Wang T; Wang W; Wang Q; Xie R; Landay A; Chen D
Ann N Y Acad Sci; 2020 Jan; 1460(1):3-10. PubMed ID: 31414713
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
11. Role of E3 ubiquitin ligases in lung cancer.
Snoek BC; de Wilt LH; Jansen G; Peters GJ
World J Clin Oncol; 2013 Aug; 4(3):58-69. PubMed ID: 23936758
[TBL] [Abstract][Full Text] [Related]
12. Robust high-throughput assays to assess discrete steps in ubiquitination and related cascades.
Fenteany G; Gaur P; Sharma G; Pintér L; Kiss E; Haracska L
BMC Mol Cell Biol; 2020 Mar; 21(1):21. PubMed ID: 32228444
[TBL] [Abstract][Full Text] [Related]
13. The role of E3 ligases in the ubiquitin-dependent regulation of spermatogenesis.
Richburg JH; Myers JL; Bratton SB
Semin Cell Dev Biol; 2014 Jun; 30():27-35. PubMed ID: 24632385
[TBL] [Abstract][Full Text] [Related]
14. Neglected PTM in animal adipogenesis: E3-mediated ubiquitination.
Ran H; Li C; Zhang M; Zhong J; Wang H
Gene; 2023 Aug; 878():147574. PubMed ID: 37336271
[TBL] [Abstract][Full Text] [Related]
15. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
[TBL] [Abstract][Full Text] [Related]
16. E3-ubiquitin ligases and recent progress in osteoimmunology.
Asano Y; Matsumoto Y; Wada J; Rottapel R
Front Immunol; 2023; 14():1120710. PubMed ID: 36911671
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
Pray TR; Parlati F; Huang J; Wong BR; Payan DG; Bennett MK; Issakani SD; Molineaux S; Demo SD
Drug Resist Updat; 2002 Dec; 5(6):249-58. PubMed ID: 12531181
[TBL] [Abstract][Full Text] [Related]
18. Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins.
Furukawa M; Ohta T; Xiong Y
J Biol Chem; 2002 May; 277(18):15758-65. PubMed ID: 11861641
[TBL] [Abstract][Full Text] [Related]
19. Targeted modulation of E3 ligases using engineered ubiquitin variants.
LeBlanc N; Mallette E; Zhang W
FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer.
Kaushik A; Parashar S; Ambasta RK; Kumar P
Ageing Res Rev; 2024 Apr; 96():102279. PubMed ID: 38521359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
